| 摘要 |
FIELD: veterinary science.SUBSTANCE: invention refers to veterinary science and is intended for elimination of thrombocyte membrane lipid content disorders in newborn calves with anaemia. Newborn calves with anaemia are assigned ferroglucinum 150 mg (2 ml) of ferroglucinum i.m., twice a day every 4 days, 5 mg/kg of cresacin a day starting simultaneously with the first injection of ferroglucinum, including it in the feed regimen for 4 days, and 0.05 ml/kg of gamavit i.m. once a day in the morning for 4 days, simultaneously with ferroglucinum and cresacin.EFFECT: use of the declared invention enables to avoid many vascular complications and optimise microcirculation and tissue trophism in animals, improve general health of livestock, reduce mortality, accelerate growth and development of calves, increase weight gain.1 cl, 1 ex |
